← All companies

BIIB

Biogen Inc.

BIIB Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$201.82

-6.11 -2.94%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$127.00 – $219.72

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Results of operations (earnings release) Jul 1, 2026 8-K Shareholder vote results Jun 10, 2026 8-K/A CURRENT REPORT Jun 10, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Results of operations (earnings release) Apr 6, 2026 8-K Entered a material agreement; Other events Mar 31, 2026 8-K Director or officer change Mar 11, 2026 8-K Director or officer change; Other events Feb 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 6, 2026 8-K Results of operations (earnings release) Feb 6, 2026 8-K Results of operations (earnings release) Jan 14, 2026 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Results of operations (earnings release) Oct 14, 2025 8-K Results of operations (earnings release) Jul 31, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 7, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Other events May 12, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Director or officer change Jan 15, 2025 8-K Director or officer change; Regulation FD disclosure Oct 30, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release) Oct 30, 2024 8-K Director or officer change Sep 12, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 25, 2024 10-Q Quarter ended 2024-03-31 Apr 24, 2024 8-K Results of operations (earnings release) Apr 24, 2024 10-K Fiscal year ended 2023-12-31 Feb 14, 2024 8-K Results of operations (earnings release) Feb 13, 2024